The developmental effects of isoflavone aglycone administration on early chick embryos

Soybeans contain the isoflavone aglycone, an endocrine disrupter. To determine the effects of small amounts of isoflavones on developmental processes, we administered 6.25, 62.5, or 625 µg isoflavone per egg to early stage (stage 10) developing chick embryos via the yolk just beneath the embryo. Egg...

Full description

Bibliographic Details
Main Authors: Kawakami Yasuhiko, Saito Kenichi, Itoh Yasuhiko
Format: Article
Language:English
Published: Sciendo 2018-10-01
Series:Interdisciplinary Toxicology
Subjects:
Online Access:https://doi.org/10.2478/intox-2018-0022
Description
Summary:Soybeans contain the isoflavone aglycone, an endocrine disrupter. To determine the effects of small amounts of isoflavones on developmental processes, we administered 6.25, 62.5, or 625 µg isoflavone per egg to early stage (stage 10) developing chick embryos via the yolk just beneath the embryo. Eggs were kept at 37±0.5 °C and >80% relative humidity, with one rotation per hour for 48 hrs. The embryos were observed under a stereomicroscope for morphological abnormalities and number of somites. Relative to control eggs, there were no significant differences in the average number of somites in eggs administered isoflavone aglycone. Isoflavone, however, had a dose associated effect on abnormal embryogenesis. Embryos treated with isoflavone aglycone showed developmental arrest not reaching somitegenesis, dysmorphology of the neural tube, and shortening of entire embryos.
ISSN:1337-9569